Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8009858 | 0.94 | MEN1 (0.53) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL10926955 | 0.86 | MEN1 (0.46) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL11543099 | 0.82 | MAPT (0.47) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL15878899 | 0.81 | AR (0.39) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL18703025 | 0.80 | MEN1 (0.44) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL11543425 | 0.80 | KMT2A (0.42) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL723018 | 0.78 | MEN1 (0.57) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL7531627 | 0.78 | MEN1 (0.45) | MEN1KMT2ACYP4F2CYP4A11PKM | |
| SCHEMBL9719079 | 0.78 | MEN1 (0.45) | MEN1KMT2ACYP4F2CYP4A11PKM | |
| SCHEMBL7941258 | 0.77 | CYP4F2 (0.69) | MEN1KMT2AMAPTATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10364304-B2 | Method for producing solid catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer | TOHO TITANIUM CO., LTD. (JP) | 2019-07-30 | — | — | US | disclosed |
| EP-1533322-B1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | TOHO TITANIUM CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| EP-2730590-B1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | TOHO TITANIUM CO LTD (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-20150368281-A1 | Platinum Compounds Of Malonic Acid Derivative Having Leaving Group Containing Amino Or Alkylamino | BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2015-12-24 | — | — | US | disclosed |
| US-9206265-B2 | Solid catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer | TOHO TITANIUM CO., LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| EP-2924044-A1 | PLATINUM COMPOUND OF MALONIC ACID DERIVATIVE HAVING LEAVING GROUP CONTAINING AMINO OR ALKYLAMINO | BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT, CO., LTD (CN) | 2015-09-30 | — | — | EP | disclosed |
| EP-2374821-B1 | MANUFACTURING METHOD OF SOLID CATALYST COMPONENT AND OF CATALYST FOR OLEFIN POLYMERIZATION | TOHO TITANIUM CO LTD (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-20140221583-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | TOHO TITANIUM CO., LTD. (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20140206827-A1 | METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | TOHO TITANIUM CO., LTD. (JP) | 2014-07-24 | — | — | US | disclosed |
| EP-2730590-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | Toho Titanium CO., LTD. (JP) | 2014-05-14 | — | — | EP | disclosed |
| EP-1829898-A1 | SOLID CATALYST COMPONENT AND CATALYST FOR POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING POLYMER OR COPOLYMER OF OLEFIN USING THE SAME | Toho Catalyst Co., Ltd. (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1790667-A1 | CATALYST FOR POLYMERIZATION OF OLEFINS AND METHOD FOR POLYMERIZATION OF OLEFINS | Toho Catalyst Co., Ltd. (JP) | 2007-05-30 | — | — | EP | disclosed |
| US-7208435-B2 | Solid catalyst component for olefin polymerization and catalyst | TOHO CATALYST CO., LTD. (JP) | 2007-04-24 | — | — | US | disclosed |
| EP-1202974-B1 | PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | PFIZER PROD INC (US) | 2005-11-09 | — | — | EP | disclosed |
| US-20050227856-A1 | Solid catalyst component for olefin polymerization and catalyst | TOHO CATALYST CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| EP-1533322-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | Toho Catalyst Co., Ltd. (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-6579982-B1 | Treating inflammation, cancer | PFIZER INC. | 2003-06-17 | — | — | US | disclosed |
| EP-1202974-A1 | PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | Pfizer Products Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001012611-A1 | PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS | PFIZER PRODUCTS INC. (US) | 2001-02-22 | — | — | WO | disclosed |
| US-4077982-A | HERBICIDES | FMC CORPORATION (US) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368281-A1 | Platinum Compounds Of Malonic Acid Derivative Having Leaving Group Containing Amino Or Alkylamino | SLC7A1, ME3, SLC7A5 | MEN1 669/4885KMT2A 1844/4885MAPT 3319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.